Hybridoma-Derived Idiotype Vaccine for Lymphoma: Approval Must Wait

Hybridoma-derived idiotype vaccines have been used for the experimental treatment of human lymphoma over the last twenty years, providing evidence of biological efficacy, clinical efficacy and clinical benefit. However, the product that has come closer to regulatory approval is unlikely to clear tha...

Full description

Saved in:
Bibliographic Details
Main Author: Maurizio Bendandi (Author)
Format: Book
Published: MDPI AG, 2010-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available